Want to join the conversation?
$SNV reported a 12.6% rise in 3Q16 earnings driven by higher revenue. Net income rose to $65.25MM or $0.51 per share from $55.37MM or $0.42 per share last year. Total revenues increased 7% to $294.1MM driven by higher net interest income and a rise in non-interest income. Adjusted EPS grew 23% to $0.52.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?